Scoop: Mountaingate to sell Relevate Health

March 10, 2026 - 22:05

Mountaingate Capital is initiating a sale process for its portfolio company, Relevate Health, a move signaling potential consolidation within the healthcare marketing sector. Relevate Health operates as a specialized commercialization partner for biopharmaceutical and medical device companies, focusing on engaging healthcare providers and patients through targeted marketing and analytics services.

The company falls within a broader category of marketing and engagement firms that have attracted significant private equity investment in recent years. Industry observers note that this segment is ripe for portfolio realignment and strategic trades as sponsors look to capitalize on built value. The upcoming sale is expected to draw interest from both financial buyers and strategic acquirers seeking to expand their capabilities in the complex healthcare marketing landscape.

Relevate, under Mountaingate's ownership, has aimed to differentiate itself by integrating data-driven insights with multichannel engagement strategies. The divestiture process comes as the demand for specialized commercialization support in healthcare remains robust, driven by an evolving regulatory environment and the continuous launch of new therapies. The transaction will be closely watched as a barometer for the valuation and appetite for similar platform companies in the current market.